Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO

Clinical trial NCT02528552 · UNKNOWN

Trial details

NCT number: NCT02528552
Sponsor: Theradome, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Androgenetic Alopecia

Start date: 2015-08-01
Primary completion: 2016-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.